laminine has been researched along with tyrosyl-isoleucyl-glycyl-seryl-arginine in 1 studies
| Studies (laminine) | Trials (laminine) | Recent Studies (post-2010) (laminine) | Studies (tyrosyl-isoleucyl-glycyl-seryl-arginine) | Trials (tyrosyl-isoleucyl-glycyl-seryl-arginine) | Recent Studies (post-2010) (tyrosyl-isoleucyl-glycyl-seryl-arginine) |
|---|---|---|---|---|---|
| 16 | 0 | 3 | 111 | 0 | 29 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dunstan, C; Michigami, T; Munday, GR; Nomizu, M; Williams, PJ; Yamada, Y; Yoneda, T | 1 |
1 other study(ies) available for laminine and tyrosyl-isoleucyl-glycyl-seryl-arginine
| Article | Year |
|---|---|
Growth and dissemination of a newly-established murine B-cell lymphoma cell line is inhibited by multimeric YIGSR peptide.
Topics: Amino Acids, Diamino; Animals; Antineoplastic Agents; Cell Division; Cell Movement; Endothelium, Vascular; Humans; Immunohistochemistry; Lymphoma, B-Cell; Mice; Mice, Nude; Neoplasm Metastasis; Neovascularization, Pathologic; Oligopeptides; Reverse Transcriptase Polymerase Chain Reaction; Tumor Cells, Cultured; Umbilical Veins | 1998 |